Fatigue in primary Sjogren's syndrome - A link to sickness behaviour in animals?

被引:53
作者
Harboe, Erna [1 ]
Tjensvoll, Anne Bolette [2 ]
Vefring, Hege K. [3 ]
Goransson, Lasse G. [1 ,6 ]
Kvaloy, Jan Terje [4 ,5 ]
Omdal, Roald [1 ,6 ]
机构
[1] Stavanger Univ Hosp, Dept Internal Med, Clin Immunol Unit, N-4068 Stavanger, Norway
[2] Stavanger Univ Hosp, Dept Neurol, N-4068 Stavanger, Norway
[3] Stavanger Univ Hosp, Dept Med Biochem, N-4068 Stavanger, Norway
[4] Stavanger Univ Hosp, Div Res & Human Resources, N-4068 Stavanger, Norway
[5] Univ Stavanger, Dept Math & Nat Sci, Stavanger, Norway
[6] Univ Bergen, Inst Internal Med, N-5020 Bergen, Norway
关键词
Sick behaviour; Primary Sjogren's syndrome; Fatigue; Interleukin-1Ra; INTERLEUKIN-1 RECEPTOR ANTAGONIST; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; CYTOKINES; BRAIN; PREVALENCE; BLOOD;
D O I
10.1016/j.bbi.2009.06.151
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin-1 beta (IL-1 beta) is involved in the regulation of sickness behaviour in response to infection and inflammation in animals. Human fatigue can be considered an element of sickness behaviour and is a prominent and often disabling phenomenon in autoimmune diseases such as primary Sjogren's syndrome (PSS). The role of the IL-1 system in the fatigue of patients with PSS was explored. A cerebrospinal fluid (CSF) analysis of IL-1 beta, IL-1Ra, and IL-1sRII was performed in 54 PSS patients and 53 control subjects. Fatigue was evaluated in the patients using the Fatigue Severity Scale (FSS) and a fatigue visual analogue scale (VAS); mood was evaluated using the Beck Depression Inventory (BDI). There were higher CSF levels of IL-1Ra pg/mL in PSS patients vs. controls (median 38.4: range 15.4-81.7 vs. 33.7: 7.3-163.1, p = 0.026). Fatigue VAS scores were associated with increasing CSF levels of IL-IRa in PSS patients (R-2 = 0.11, p = 0.015). In a subgroup analysis of the non-depressed PSS patients (N = 37; 69%), the association between VAS scores and IL-1Ra was even stronger (R-2 = 0.20, p = 0.006). The positive association between VAS scores and IL-1Ra remained significant in a multiple regression analysis adjusting for age and BDI scores. Increased levels of IL-1Ra in the CSF are associated with increasing fatigue in PSS patients, indicating that the activated IL-1 system is a possible biological factor associated with fatigue. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:1104 / 1108
页数:5
相关论文
共 37 条
[1]   Influence of BMI on Health-related Quality of Life: Comparison Between an Obese Adult Cohort and Age-matched Population Norms [J].
Anandacoomarasamy, Ananthila ;
Caterson, Ian D. ;
Leibman, Steven ;
Smith, Garett S. ;
Sambrook, Philip N. ;
Fransen, Marlene ;
March, Lyn A. .
OBESITY, 2009, 17 (11) :2114-2118
[2]   Measurement of fatigue in systemic lupus erythematosus: A systematic review [J].
不详 .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (08) :1348-1357
[3]   Interleukin-1 receptor antagonist: Role in biology [J].
Arend, WP ;
Malyak, M ;
Guthridge, CJ ;
Gabay, C .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :27-55
[4]   Passage of cytokines across the blood-brain barrier [J].
Banks, WA ;
Kastin, AJ ;
Broadwell, RD .
NEUROIMMUNOMODULATION, 1995, 2 (04) :241-248
[5]  
Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151
[6]   Role of interleukin-1β and tumour necrosis factor-α in lipopolysaccharide-induced sickness behaviour:: a study with interleukin-1 type I receptor-deficient mice [J].
Bluthé, RM ;
Layé, S ;
Michaud, B ;
Combe, C ;
Dantzer, R ;
Parnet, P .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (12) :4447-4456
[7]   Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK [J].
Bowman, SJ ;
Ibrahim, GH ;
Holmes, G ;
Hamburger, J ;
Ainsworth, JR .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2004, 33 (01) :39-43
[8]   BEHAVIORAL-EFFECTS OF PERIPHERALLY INJECTED INTERLEUKIN-1 - ROLE OF PROSTAGLANDINS [J].
CRESTANI, F ;
SEGUY, F ;
DANTZER, R .
BRAIN RESEARCH, 1991, 542 (02) :330-335
[9]   Cytokine-induced sickness behavior: Where do we stand? [J].
Dantzer, R .
BRAIN BEHAVIOR AND IMMUNITY, 2001, 15 (01) :7-24
[10]  
Dellalibera-Joviliano R, 2003, J RHEUMATOL, V30, P485